tiprankstipranks
Abivax Initiates $150 Million ATM Program on Nasdaq
Company Announcements

Abivax Initiates $150 Million ATM Program on Nasdaq

Abivax SA Sponsored ADR (ABVX) has released an update.

Pick the best stocks and maximize your portfolio:

Abivax has launched an At-The-Market (ATM) program on Nasdaq, allowing the company to raise up to $150 million by issuing American Depositary Shares (ADS) over the next three years. This strategic move is aimed at supporting its clinical programs and general corporate purposes, providing flexibility in its financing strategy. Piper Sandler & Co. will act as the sales agent, facilitating the sale of ADSs to eligible investors.

For further insights into ABVX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyAbivax initiated with an Outperform at JMP Securities
TipRanks Auto-Generated NewsdeskAbivax Reports Strong Q3 Financials and Clinical Progress
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App